Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederendpoints.news
Endpoints News
Get the latest updates from Endpoints News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated over 1 year ago
Endpoints livestream: RFK Jr. fired the CDC's vaccine panel, and what happens next
over 1 year ago
Today on Post-Hoc Live, we’re going to dig into HHS Secretary Robert...
FDA places hold on Gilead's studies of HIV treatment pill combo
over 1 year ago
The FDA ordered Gilead to pause studies of two long-acting HIV pills...
FDA chief Makary says he wasn’t involved in decision to fire ACIP members
over 1 year ago
FDA Commissioner Marty Makary said he wasn’t involved in HHS Secretary Robert...
Argenx says its drug Vyvgart looks promising in two more autoimmune diseases
over 1 year ago
The Dutch biotech argenx has big plans for its autoimmune disease drug...
Vertex lays off 125 workers after type 1 diabetes cell therapy failed study in March
over 1 year ago
Vertex Pharmaceuticals is letting go of 125 employees in Rhode Island after...
SpliceBio gets $135M shortly after starting first clinical trial
over 1 year ago
In the difficult field of gene therapies, some biotech startups are still...
Basecamp Research CEO on fixing the 'data wall' in AI bio
over 1 year ago
From hiking through rainforests to diving into the ocean's depths, the scientist-explorers...
BMS’ RayzeBio bags rights for Philochem’s radiopharma asset for $350M upfront
over 1 year ago
Bristol Myers Squibb’s subsidiary RayzeBio is spending $350 million upfront to license...
Novo marks seventh cardiometabolic deal of the year with Deep Apple Therapeutics
over 1 year ago
Novo Nordisk has been on a dealmaking spree this year to assuage...
Reality check: Unpacking the $150B GLP-1 market forecasts
over 1 year ago
Market expectations for GLP-1 agonists have been high for some time. But...
Vaxart shares rise after reporting norovirus vaccine data
over 1 year ago
A small vaccine maker's stock price shot up Wednesday after releasing new...
Lilly pledges more than $650M to muscle health biotech; Cogent gets $50M
over 1 year ago
Plus, news about Cellectar Biosciences, Bausch + Lomb, Elkedonia, Pharmazz and Roche...